Colgate-Palmolive's third-quarter results put a familiar strength beside an uncomfortable exception. The consumer-products group reported a 60.2% gross margin and growing sales worldwide, but its North America division suffered a 3.7% volume decline. At roughly 24 times expected earnings, investors are paying for a business whose brand strength still needs to translate into a regional recovery.
The October 30 release showed sales rising 4.6% to $5.369 billion, with organic growth of 3.6%. GAAP earnings per share increased 3% to $0.94; the company's non-GAAP base-business measure rose 7% to $0.97. The distinction matters because restructuring costs affect the reported result.
Productivity is paying for brand investment
The gross-margin improvement was substantial: 80 basis points on a reported basis and 90 basis points to 60.3% excluding specified charges. Yet its composition is more revealing than the headline. Productivity contributed 290 basis points, almost offsetting a 300-basis-point raw-material headwind. Pricing added 80 basis points and product mix another 20.
That bridge, detailed in the company's prepared management remarks, suggests the margin recovery depends on operating execution as well as the ability to charge more. Cost savings protected the business from inflation, leaving pricing to contribute to expansion. A strong brand helps, but manufacturing and supply-chain discipline are doing considerable work.
Much of that financial room is being reinvested. Advertising increased approximately 15% to $775 million, faster than sales. On the base-business comparison, operating margin rose only 20 basis points to 20.8%, well below the gross-margin improvement. Reported operating margin fell 30 basis points to 20.3%. Investors are receiving a modest adjusted operating-margin improvement alongside a much larger commitment to brand support.
For a long-term investor, this need not be a weakness. Advertising can support product launches, reinforce consumer habits and protect future pricing. Taking every efficiency gain immediately into profit could leave brands less competitive. The unresolved question is whether the additional spending creates durable demand or becomes a higher recurring cost required to maintain existing business.
Global leadership leaves a North American exception
Colgate reported year-to-date global value shares of 41.4% in toothpaste and 33.1% in manual toothbrushes. Those figures support the case for substantial brand and distribution advantages. They measure sales value in tracked markets, however, with incomplete coverage of some retail channels. They do not establish that unit demand is rising everywhere.
North America illustrates that limitation. The division, representing 17% of group sales, recorded a 1.6% organic sales decline despite 2.2% higher pricing. Operating profit fell 11% to $177 million, and its margin contracted 210 basis points to 19.5%. These are regional divisional results, covering more than toothpaste alone; they should not be interpreted as a direct measure of lost oral-care share.
The economic concern is nevertheless clear. Higher prices could not offset lower volumes, while regional profitability weakened. Strong market positions provide resources to respond, but they do not establish how quickly consumers will buy more. Nor can one quarter isolate the effects of category conditions, retailer orders, competition and Colgate's own commercial decisions.
The strongest counterargument comes from the rest of the portfolio. Latin America's organic sales rose 6%, supported by both pricing and volume. Hill's Pet Nutrition delivered 5.7% organic growth. Those businesses represented 25% and 22% of group sales, respectively. Geographic reach and pet nutrition allow Colgate to fund a North American response without depending entirely on that division's recovery.
The valuation requires a return on reinvestment
Cash generation reinforces that flexibility. The third-quarter filing accompanied results showing nine-month operating cash flow of $2.913 billion and capital expenditure of $400 million. Free cash flow before dividends was therefore $2.513 billion, up about 7%, against approximately $2.2 billion returned through dividends and repurchases. Brand spending has not prevented meaningful cash returns.
At the October 30 close of $95.29, Colgate's market capitalization was approximately $75.75 billion. Valuation data put the forward earnings multiple at about 24, based on analyst estimates, and price to trailing free cash flow near 20, equivalent to a roughly 5% equity cash yield.
The 37.2-times trailing P/E is less representative of ongoing profitability because reported earnings include charges, notably the prior-year skin-health impairments. But using adjusted or forward earnings does not make their underlying assumptions certain. Management expects base-business EPS growth of 5%–7% this year; the forward multiple reflects a separate set of analyst forecasts.
A premium can be justified by Colgate's global positions, productivity and cash conversion. The risk is that investors capitalize those strengths while underestimating the spending needed to sustain them. If North American volumes remain weak, higher advertising could support the franchise without delivering enough additional profit to support the valuation.
Colgate has demonstrated that it can protect gross profitability and finance its brands. The next proof should come from stronger demand and healthier North American operating economics. Until reinvestment delivers that improvement, a 60% gross margin supports the quality case more convincingly than it establishes value at the current share price.
Sources
- Colgate-Palmolive third-quarter 2026 results, October 30, 2026
- Colgate-Palmolive third-quarter 2026 prepared management remarks
- Colgate-Palmolive Form 10-Q for the quarter ended September 30, 2026
- Colgate-Palmolive share-price history and October 30 closing price
- Colgate-Palmolive valuation and financial statistics
- Colgate-Palmolive fourth-quarter 2025 results and skin-health impairment charges
